Follow for more talkers

Diabetes pills may help slash risk of Alzheimer’s

Avatar photo

Published

on
Closeup portrait of happy middle aged 50s woman holding pill taking dietary supplements. Portrait of smiling adult attractive woman taking collagen vitamins health in menopause.
(Ground Picture via Shutterstock)

This story version has been formatted as an on-air script for broadcast outlets. See the original research story here.

COMMON DIABETES PILLS CAN REDUCE THE RISK OF DEMENTIA BY MORE THAN 20 PERCENT, ACCORDING TO NEW RESEARCH.

KNOWN AS TZDS (THIAZOLIDINEDIONES), THE PILLS BOOST BLOOD FLOW BY REDUCING BAD CHOLESTEROL - INCREASING OXYGEN SUPPLY TO THE BRAIN. THEY ALSO TARGET INSULIN RESISTANCE.

RESEARCHES SAY PEOPLE WITH TYPE 2 DIABETES ARE MORE VULNERABLE TO DEMENTIA AS BOTH CONDITIONS ARE LINKED TO POOR CIRCULATION.

THE FINDINGS ARE BASED ON ELECTRONIC HEALTH RECORDS OF NEARLY 560,000 US VETERANS DIAGNOSED WITH TYPE 2 DIABETES BETWEEN JANUARY 2000 TO DECEMBER 2019.

AFTER AT LEAST ONE YEAR OF TREATMENT, TZD WAS ASSOCIATED WITH A 22 PERCENT LOWER RISK OF DEMENTIA, COMPARED WITH THE USE OF OTHER DIABETES DRUGS.

THE NUMBER OF PEOPLE LIVING WITH IT IS SET TO TRIPLE TO MORE THAN 150 MILLION WORLDWIDE BY 2050.

THE STUDY IS PUBLISHED IN BMJ OPEN DIABETES RESEARCH & CARE.

Stories and infographics by ‘Talker Research’ are available to download & ready to use. Stories and videos by ‘Talker News’ are managed by SWNS. To license content for editorial or commercial use and to see the full scope of SWNS content, please email [email protected] or submit an inquiry via our contact form.

Continue Reading

Top Talkers